Skip to main content
. 2019 Jan 10;8(1):70. doi: 10.3390/jcm8010070

Table 6.

Disease severity with regard to the CTLA-4 rs3087243 genotypes.

Variable All (n = 644) rs3087243 p-Value
AA (n = 142) GG/AG (n = 502)
SOFA 7.0 ± 3.5 7.4 ± 3.8 6.9 ± 3.5 0.3005
SOFA-Respiratory score 2.0 ± 0.8 2.0 ± 0.8 2.0 ± 0.8 0.6043
SOFA-Cardiovascular score 1.5 ± 1.0 1.7 ± 1.0 1.5 ± 1.0 0.1284
SOFA-Central Nervous System score 2.0 ± 1.1 2.2 ± 1.0 1.9 ± 1.1 0.0094
SOFA-Renal score 0.8 ± 1.2 0.7 ± 1.1 0.8 ± 1.2 0.6669
SOFA-Coagulation score 0.4 ± 0.6 0.4 ± 0.7 0.3 ± 0.6 0.5521
SOFA-Hepatic score 0.4 ± 0.7 0.4 ± 0.7 0.4 ± 0.7 0.9780
Organ support
Ventilation days/observation days (%) 66 ± 32 71 ± 32 65 ± 32 0.0280
Vasopressor days/observation days (%) 34 ± 30 37 ± 33 33 ± 29 0.2919
Dialysis days/observation days (%) 9 ± 23 9 ± 23 10 ± 22 0.8287
Inflammatory values
Leucocytes (1000/µL) 13 ± 5 13 ± 5 13 ± 5 0.1026
CRP (mg/L) 152 ± 87 137 ± 81 156 ± 88 0.1356
Procalcitonin (ng/dL) 4.0 ± 9.3 3.5 ± 10.1 4.1 ± 9.1 0.0655
Kidney values
Urine output (mL/day) 2978 ± 1337 2973 ± 1388 2979 ± 1324 0.9387
Urine output (mL/kg/day) 1.6 ± 0.8 1.6 ± 0.8 1.6 ± 0.78 0.9051
Creatinine (mg/dL) 1.2 ± 0.9 1.2 ± 0.9 1.3 ± 1.0 0.4218
Liver values
AST (GOT) (IU/L) 169 ± 598 127 ± 238 182 ± 672 0.7476
ALT (GPT) (IU/L) 94 ± 188 101 ± 193 92 ± 187 0.2135
Bilirubin (mg/dL) 1.2 ± 2.1 1.2 ± 1.8 1.2 ± 2.1 0.5972

CRP, C-reactive protein; AST, aspartate transaminase; GOT, glutamic oxaloacetic transaminase; ALT, alanine transaminase; GPT, glutamate-pyruvate transaminase.